Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

.

Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

European regulatory authorities on Thursday said an Abbott Laboratories (ABT) diet pill should be banned from sale in the market, issuing tougher warnings for the drug because the drug poses high risks of stroke and heart attack.

The warning was conveyed after a study of 10,000 patients suggested it put them at a higher risk for heart disease.

The study revealed 11.4% of those who used Meridia as a medication faced a cardiovascular event such as a heart attack, compared with 10% of patients who received a fake pill.

This medicine is sold in Europe under the brand-names Reductil, Reduxade, Zelium and other names; and as Meridia in the U. S.

The warning for not to use Meridia is to include patients with a history of problems as Coronary artery disease, heart attack, transient ischemic attack, Arrhythmia, Congestive heart failure, Peripheral arterial disease, uncontrolled hypertension.

The agency's decision will now get passed to the European Commission for review.

The FDA said Abbott has agreed to update the label bearing “recommended the drug shouldn't be used in patients with a history of heart disease, “and further plans to convene an advisory committee meeting to further discuss the safety and risks with Meridia.


Latest News

Somali refugee sets herself on fire at Australian immigration camp on Nauru
Former FBI agents stole $136,000 for personal use
Arlington Agrees to Sell Itself to Oracle for $532 Million
Puerto Rico Misses Bond Payments, Expects Help from Congress to Rescue it From t
Greenlight Capital Invest in Yelp and Natural Gas; Exits Greek Banks and Delta L
Colorado’s Supreme Court Strikes Down Prohibitions on Hydraulic Fracking by the
To mark five years of operation to capture Osama, CIA tweets details
Sanders to continue fight for nomination
Reportedly, Englewood Based Sports Authority to Shutter All Stores in the U.S
Puerto Rico’s Governor says the American Territory Cannot Pay Most of its $370Mi
Chicago Mayor Says Hotel on Navy Pier Planned as Part of Navy Pier’s Centennial
Oil Field Service Provider Halliburton and Baker Hughes Give Up Plan of $28 Bill